Clinical Trial Update: Efficacy and Safety of AZD7009 in the Treatment of Atrial Fibrillation [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate the efficacy and safety of AZD7009 in patients with atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• AZD7009

Snippet

Sponsor: AstraZeneca | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED